Nowakowski, G., Hoffmann, M., Muñoz, J., Westin, J., Garcia-Sancho, A. M., Kwiatek, M., Jurczak, W., Bouzani, M., Moustafa, M. A., Sudhindra, A., Gkasiamis, A., Patel, A., Boucaud, F., Perna, S., Vassilakopoulos, T. (2025). Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, plus R-CHOP in patients (Pts) with previously untreated aggressive B-cell lymphoma (a-BCL): 24-month efficacy Results. Blood. https://doi.org/10.1182/blood-2025-476